The BCG Vaccine SSI from CSL is currently being used for the Neonatal BCG Programme.
BCG Vaccine is offered to infants and children less than five years of age to protect against severe forms of tuberculosis in infants and young children e.g. meningeal TB (infection of the layers over the brain) and miliary TB.
sanofi-aventis recalled the BCG vaccine used in New Zealand. This is a precautionary recall as checks of the air quality at the vaccines manufacturing site found a problem and sanofi-aventis cannot be completely confident that the vaccine is sterile. There are no reasons for anyone who has received this vaccine to be concerned as this is recall is being taken as a precaution only. More details ...
